Body Pain
Epidemiology: Nucoxia D3 is a unique combination of Etoricoxib (90mg) and Vitamin D3 (600IU). Both these components help in pain relief as well as in elimination of the root cause of unspecified and vague body pain. It has been studied that this unspecified and vague body pain is due to various reasons like Fibromyalgia, Chronic Fatigue Syndrome and even Osteoporosis. Such patients need immediate pain relief along with something which addresses the root cause as well. Thus Nucoxia D3 is the safest option.
Many studies have suggested that Vitamin D3 has a role in managing chronic pain because it acts on neuronal of pain by regulating the neurotransmitters like GABA, NT3 and Neural growth factor. Thus, when given with an effective and safe NSAID like Etoricoxib, Vitamin D3 acts as co-analgesic. Also, there are various studies which show that daily supplementation of Vitamin D3 has been found to be effective in managing pain associated with Fibromyalgia, Chronic Fatigue Syndrome, and Osteoporosis.
Who can be affected: In India, 60% of women above the age of 25 years suffer from unspecified and vague body pain. Pain caused due to activation of sensory nervous system & inter-neurons. It majorly affects woman due to hormonal changes. An unspecified and vague body pain doesn’t have a specific reason. A person suffering from the pain experiences chronic body pain throughout the body. As a result of that, there is extreme fatigue and stress. Furthermore, it brings about anxiety and depression.
An unspecified and vague body pain is a result of Fibromyalgia, Chronic Fatigue Syndrome, and body pain due to Osteoporosis. Osteoporosis can be further classified into Osteopenia and Osteomalacia.
Types of Pain:
An unspecified and vague body pain is a result of Fibromyalgia, Chronic Fatigue Syndrome, and body pain due to Osteoporosis. Osteoporosis can be further classified into Osteopenia and Osteomalacia.
Fibromyalgia
    It is a common chronic clinical condition characterized by widespread pain (CWP). It causes fatigue, sleep, memory, and mood bowel syndrome, anxiety, and depression. It is the second most common disorder after Osteoarthritis as per Orthopedicians. The majority of the population affected by FM includes women. Around 85-90% of the affected populations are women. Dorsal pain is the most common thing in Fibromyalgia. Under FM, an individual suffers pain at 11 out of 18 points in the body.
Chronic Fatigue Syndrome
    It is characterized by extreme fatigue. It most commonly affects the brain, muscles, and joints. It involves continuous body pain and sleep disturbances. The fatigue may worsen with physical or mental activity but doesn't improve with rest.
Osteoporosis
    Osteoporosis is low bone mass and micro-architectural disruption causing weakening of bone. It leads to unexplained chronic body pain and is caused due to loss of calcium from the bones. Osteopenia is an early stage of Osteoporosis. Muscle weakness and body pain with fatigue are common symptoms of Osteopenia. While softening of unmineralized bones is caused due to Osteomalacia
Diagnosis: A unique combination of Etoricoxib (90mg) and Vitamin D3 (600IU). Etoricoxib is ideal for effective pain relief whereas Vitamin D3 will help to eliminate the root cause of the pain.
Many studies have suggested that Vitamin D3 has a role in managing chronic pain because it acts on the neuronal of pain by regulating the neurotransmitters like GABA, NT3 and the Neural growth factor. Thus when given with an effective and safe NSAID like Etoricoxib, Vitamin D3 acts as a co-analgesic. Also, there are various studies which show that daily supplementation of Vitamin D3 has been found to be effective in managing pain associated with Fibromyalgia, Chronic Fatigue Syndrome, and Osteoporosis.